What other stocks do shareholders of Amylin Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amylin Pharmaceuticals investors own include Chipotle Mexican Grill (CMG) , Booking (BKNG) , BlackBerry (BB) , Bank of America (BAC) , Arena Pharmaceuticals (ARNA) , Ariad Pharmaceuticals (ARIA) , Alpha Natural Resources (ANRZQ) , Amarin (AMRN) and AEGR (AEGR) .

NASDAQ:AMLN

Amylin Pharmaceuticals (AMLN) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free AMLN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Amylin Pharmaceuticals alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Amylin Pharmaceuticals Stock (NASDAQ:AMLN)

Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. It markets two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. It is also markets a diabetes treatment, BYDUREON (exenatide extended-release for injectable suspension). BYDUREON is an extended-release medication for type 2 diabetes that provides continuous glycemic control in a once-weekly dose. Amylin maintains a research and early development program focused on peptide and protein therapeutics. It has also entered into alliances and business initiatives, including its relationship with Biocon, Limited (Biocon) to develop pharmaceutical products, including AC165198, a peptide hybrid drug candidate for diabetes, which was developed from its phybrid technology platform. In August 2012, Bristol-Myers Squibb Company acquired the Company.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

AMLN Stock News Headlines

March 19, 2024 | benzinga.com

Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary

March 7, 2024 | businessinsider.com

BANK OF AMERICA: Weight-loss drugs like Ozempic are being supplied or developed by these 16 stocks — and their use is expected to skyrocket by 2035

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

May 21, 2023 | thestreet.com

Amylin Stock Falls On Unusually High Volume (AMLN)

August 26, 2022 | thestreet.com

Dion's ETF Winners and Losers: VXX, FBT

May 2, 2022 | thestreet.com

How to Value Biotech Stocks

September 12, 2021 | benzinga.com

Daniel Bradbury

See More Headlines

Receive AMLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amylin Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:AMLN
CUSIP: N/A
CIK: 881464
Web: www.amylin.com
Phone: +1-858-5522200
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

AMLN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Amylin Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Amylin Pharmaceuticals investors own include Chipotle Mexican Grill (CMG), Booking (BKNG), BlackBerry (BB), Bank of America (BAC), Arena Pharmaceuticals (ARNA), Ariad Pharmaceuticals (ARIA), Alpha Natural Resources (ANRZQ), Amarin (AMRN) and AEGR (AEGR).

This page (NASDAQ:AMLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Amylin Pharmaceuticals (AMLN) Stock Price, News & Analysis

About Amylin Pharmaceuticals Stock (NASDAQ:AMLN)

AMLN Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

AMLN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info